Efficacy of Oral Febuxostat drug for Slowing the Glomerular Filtrate Rate Decline in Patients With Chronic Kidney Disease and Asymptomatic Hyperuricemia: A 6-Month, Single-Blind, Randomized, Placebo-Controlled Trial